T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors

NCT02442297 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor, Recurrent
Brain Tumor, Refractory

Interventions

BIOLOGICAL: HER2-specific T cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]